Abstract
We report the combination of chemical cross-linking and high-resolution mass spectrometry for analyzing conformational changes in target proteins that are induced by drug binding. With this approach conformational changes in the peroxisome proliferator-activated receptor alpha (PPARalpha) upon binding of low-molecular weight compounds were readily detected, proving that the strategy provides a basis to efficiently characterize target protein-drug interactions.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Crystallography, X-Ray
-
Drug Discovery
-
Hydrolysis
-
Ligands
-
Mass Spectrometry
-
Models, Molecular
-
Oxazoles / chemistry
-
Oxazoles / metabolism
-
Oxazoles / pharmacology
-
PPAR alpha / agonists
-
PPAR alpha / antagonists & inhibitors
-
PPAR alpha / chemistry
-
PPAR alpha / metabolism*
-
Pharmaceutical Preparations / chemistry
-
Pharmaceutical Preparations / metabolism*
-
Protein Binding
-
Protein Conformation / drug effects
-
Reproducibility of Results
-
Tyrosine / analogs & derivatives
-
Tyrosine / chemistry
-
Tyrosine / metabolism
-
Tyrosine / pharmacology
Substances
-
GW 6471
-
Ligands
-
Oxazoles
-
PPAR alpha
-
Pharmaceutical Preparations
-
Tyrosine